Characterization of an alkaline subtilopeptidase type Pfizer
The physiochemical properties, amino acid composition and profile of the the tryptic peptides for an alkaline subtilopeptidase type Pfizer have been determined. The enzyme is stable in the pH range from 5 to 10, has a pH optimum of 9.5 to 10, and is relatively stable for a period of 2 h up to a temperature of 50C. Homogeneity was demonstrated by electrophoretic techniques and the mobilities indicated on isoelectric point of 8.7. The molecular weight was found to be 25,000 by gel filtration. The amino acid composition was found to be Ala32, Arg4, Aspgamma8, Glu15, Gly29, His4, Ile9, Leu13, Lys11, Met5, Phe4, Pro14, Ser31, Thr17, Tyr9, Val22, a total of 247 amino acid residues. The enzyme does not contain either disulfide bonds or cysteine, and lacks tryptophan as well. The N-terminal end-group residue is alanine: the C-terminal amino acid is arginine. Tryptic hydrolysis of the enzyme produced 15 peptides which were separated by gradient elution on Dowex 50-X2. The amino acid composition of each appropriately purified tryptic peptide was established.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1976 |
---|---|
Erschienen: |
1976 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
International journal of peptide and protein research - 8(1976), 2 vom: 13., Seite 141-53 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Munnelly, K P [VerfasserIn] |
---|
Themen: |
Amino Acids |
---|
Anmerkungen: |
Date Completed 03.08.1976 Date Revised 02.09.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM000060623 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM000060623 | ||
003 | DE-627 | ||
005 | 20231221010027.0 | ||
007 | tu | ||
008 | 231221s1976 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0001.xml |
035 | |a (DE-627)NLM000060623 | ||
035 | |a (NLM)5381 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Munnelly, K P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Characterization of an alkaline subtilopeptidase type Pfizer |
264 | 1 | |c 1976 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 03.08.1976 | ||
500 | |a Date Revised 02.09.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The physiochemical properties, amino acid composition and profile of the the tryptic peptides for an alkaline subtilopeptidase type Pfizer have been determined. The enzyme is stable in the pH range from 5 to 10, has a pH optimum of 9.5 to 10, and is relatively stable for a period of 2 h up to a temperature of 50C. Homogeneity was demonstrated by electrophoretic techniques and the mobilities indicated on isoelectric point of 8.7. The molecular weight was found to be 25,000 by gel filtration. The amino acid composition was found to be Ala32, Arg4, Aspgamma8, Glu15, Gly29, His4, Ile9, Leu13, Lys11, Met5, Phe4, Pro14, Ser31, Thr17, Tyr9, Val22, a total of 247 amino acid residues. The enzyme does not contain either disulfide bonds or cysteine, and lacks tryptophan as well. The N-terminal end-group residue is alanine: the C-terminal amino acid is arginine. Tryptic hydrolysis of the enzyme produced 15 peptides which were separated by gradient elution on Dowex 50-X2. The amino acid composition of each appropriately purified tryptic peptide was established | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Amino Acids |2 NLM | |
650 | 7 | |a Endopeptidases |2 NLM | |
650 | 7 | |a EC 3.4.- |2 NLM | |
650 | 7 | |a Trypsin |2 NLM | |
650 | 7 | |a EC 3.4.21.4 |2 NLM | |
700 | 1 | |a Kapoor, A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of peptide and protein research |d 1972 |g 8(1976), 2 vom: 13., Seite 141-53 |w (DE-627)NLM000004421 |x 0367-8377 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:1976 |g number:2 |g day:13 |g pages:141-53 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 1976 |e 2 |b 13 |h 141-53 |